Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count

Journal of Medical Virology

Volumn 79, Issue 10, 2007, Pages 1562-1568

  De Souza, Vanda Akico Ueda Fick ^a   Pierrotti, Ligia Camera ^a   Sumita, Laura Masami ^a   Freire, Wilton Santos ^a   Segurado, Aluisio Augusto Cotrim ^a   Pannuti, Cláudio Sérgio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

HHV 8; Humoral response; KSHV; LANA; Lytic

Indexed keywords

ANTIRETROVIRUS AGENT; CELL NUCLEUS ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOFLUORESCENCE; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; SEROCONVERSION; SEROLOGY; SEXUALITY;

HUMAN HERPESVIRUS 8;

EID: 34548224204     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20949     Document Type: Article

References (38)

1. Biggar RJ, Engels EA, Whitby D, Kedes DH, Goedert JJ. 2003. Antibody reactivity to latent and lytic antigens to human herpesvirus-8 in longitudinally followed homosexual men. J Infect Dis 187:12-18.
2. Boshoff C, Weiss RA. 2001. Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci 356:517-534.
3. Campbell TB, Fitzpatrick L, MaWhinney S, Zhang X, Schooley RT. 1999. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) infection in men receiving treatment for HIV-1 infection. J Acquir Immune Dene Syndr 22:333-340.
4. Cattani P, Capuano M, Cerimele F, La Parola IL, Santangelo R, Masini C, Cerimele D, Fadda G. 1999. Human herpesvirus 8 seroprevalence and evaluation of nonsexual transmission routes by detection of DNA in clinical specimens from human immunodeficiency virus-seronegative patients from central and southern Italy, with and without Kaposi's sarcoma. J Clin Microbiol 37:1150-1153.
5. Cattelan AM, Calabro ML, Gasperini P, Aversa SM, Zanchetta M, Meneghetti F, De Rossi A, Chieco-Bianchi L. 2001. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome. J Natl Cancer Inst Monogr 28:44-49.
6. Chandran B, Smith MS, Koelle DM, Corey L, Horvat R, Goldstein E. 1998. Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of KSHV-specific proteins and glycoproteins and the encoding cDNAs. Virology 243:208-217.
7. Cockerell CJ. 1991. Histopathological features of Kaposi's sarcoma in HIV infected individuals. Cancer Surv 10:73-89.
8. Corchero JL, Mar EC, Spira TJ, Pellett PE, Inoue N. 2001. Comparison of serologic assays for detection of antibodies against human herpesvirus 8. Clin Diagn Lab Immunol 8:913-921.
9. Dupin N, Marcelin AG, Gorin I, Bossi P, Franck N, Weill B, Huraux JM, Escande JP, Calvez V. 1998. Prevalence of human herpesvirus 8 infection measured by antibodies to a latent nuclear antigen in patients with various dermatologic diseases. Arch Dermatol 134: 700-702.
10. Enbom M, Sheldon J, Lennette E, Schulz T, Ablashi DV, Neipel F, Biberfeld P, Carlberg H, Ljungman P, Nilsson A, Soderstrom T, Wadstrom J, Linde A. 2000. Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: Variable frequencies found in a multicenter serological study. J Med Virol 62:498-504.
11. Engels EA, Whitby D, Goebel PB, Stossel A, Waters D, Pintus A, Contu L, Biggar RJ, Goedert JJ. 2000. Identifying human herpesvirus 8 infection: Performance characteristics of serologic assays. J Acquir Immune Defic Synd 23:346-354.
12. Friedman-Birnbaum R, Weltfriend S, Pollack S. 1991. Classic Kaposi's sarcoma: T-lymphocyte subsets, T4/T8 ratio, and NK cell activity. J Am Acad Dermatol 24:937-940.
13. Gao SJ, Kingsley L, Li M, Zheng W, Parravicini C, Ziegler J, Newton R, Rinaldo CR, Saah A, Phair J, Detels R, Chang Y, Moore PS. 1996. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 2:925-928.
14. Goudsmit J, Renwick N, Dukers NH, Coutinho RA, Heisterkamp S, Bakker M, Schulz TF, Cornelissen M, Weverling GJ. 2000. Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984-1997): analysis of seroconversions to ORF65 and O RF73. Proc Natl Acad Sci USA 97:4838-4843.
15. Hudnall SD, Chen T, Rady P, Tyring S, Allison P. 2003. Human herpesvirus 8 seroprevalence and viral load in healthy adult blood donors. Transfusion 43:85-90.
16. Inoue N, Mar EC, Dollard SC, Pau CP, Zheng Q, Pellet PE. 2000. New immunofluorescence assays for detection of human Herpesvirus - specific antibodies. Clin Diagn Lab Immunol 7:427-435.
17. Katano H, Iwasaki T, Baba N, Terai M, Mori S, Iwamoto A, Kurata T, Sata T. 2000. Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma. J Virol 74: 3478-3485.
18. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. 1996. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 2:918-924.
19. Keller R, Zago A, Viana MC, Bourboulia D, Desgranges C, Casseb J, Moura WV, Dietze R, Collandre H. 2001. KSHV infection in patients with AIDS-related Kaposi's sarcoma in Brazil. Braz J Med Biol Res 34:879-886.
20. Kestens L, Melbye M, Biggar RJ, Stevens WJ, Piot P, De Muynck A, Taelman H, De Feyter M, Paluku L, Gigase PL. 1985. Endemic African Kaposi's sarcoma is not associated with immunodeficiency. Int J Cancer 36:49-54.
21. Krigel RL, Laubenstein LJ, Muggia FM. 1983. Kaposi's sarcoma: A new staging classification. Cancer Treat Rep 67:531-534.
22. Lennette ET, Blackbourn DJ, Levy JA. 1996. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 348:858-861.
23. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998. 338:948-954.
24. Martin JN, Amad Z, Cossen C, Lam PK, Kedes DH, Page-Shafer KA, Osmond DH, Forghani B. 2000. Use of epidemiologically well-defined subjects and existing immunofluorescence assays to calibrate a new enzyme immunoassay for human herpesvirus 8 antibodies. J Clin Microbiol 38:696-701.
25. Martro E, Bulterys M, Stewart JA, Spira TJ, Cannon MJ, Thacher TD, Bruns R, Pellett PE, Dollard SC. 2004. Comparison of human herpesvirus 8 and Epstein-Barr virus seropositivity among children in areas endemic and non-endemic for Kaposi's sarcoma. J Med Virol 72:126-131.
26. Ministério da Saúde. 2007. Recomendações para terapia anti-retroviral em adolescentes e adultos infectados pelo HIV. Available at http://www.aids.gov.br. Accessed 29 January 2007.
27. Nascimento MC, de Souza VA, Sumita LM, Freire W, Munoz F, Kim J, Pannuti CS, Mayaud P. 2007. Comparative study of Kaposi's sarcoma-associated herpesvirus (KSHV) serological assays using clinically and serologically defined reference standards and latent class analysis. J Clin Microbiol 45:715-720.
28. Pellett PE, Wright DJ, Engels EA, Ablashi DV, Dollard SC, Forghani B, Glynn SA, Goedert JJ, Jenkins FJ, Lee TH, Neipel F, Todd DS, Whitby D, Nemo GJ, Busch MP. Retrovirus Epidemiology Donor Study. 2003. Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion 43:1260-1268.
29. Quinlivan EB, Wang RX, Stewart PW, Kolmoltri C, Regamey N, Erb P, Vernazza PL, Swiss HIV Cohort Study. 2001. Longitudinal seroreactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS. J Med Virol 64:157-166.
30. Rabkin CS, Schulz TF, Whitby D, Lennette ET, Magpantay LI, Chatlynne L, Biggar RJ. 1998. Interassay correlation of human herpesvirus 8 serologic tests. KSHV Interlaboratory Collaborative Group. J Infect Dis 178:304-309.
31. Renne R, Zhong W, Herndier B, McGrath M, Abbey N, Kedes D, Ganem D. 1996. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nature Med 2:342-346.
32. Rezaee SA, Cunningham C, Davison AJ, Blackbourn DJ. 2006. Kaposi's sarcoma-associated herpesvirus immune modulation: An overview. J Gen Virol 87:1781-1804.
33. Rezza G, Lennette ET, Giuliani M, Pezzotti P, Caprilli F, Monini P, Butto S, Lodi G, Di Carlo A, Levy JA, Ensoli B. 1998. Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections. Int J Cancer 77:361-365.
34. Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, Rainbow L, Howard MR, Gao SJ, Bohenzky RA, Simmonds P, Lee C, de Ruiter A, Hatzakis A, Tedder RS, Weller IV, Weiss RA, Moore PS. 1996. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 348:1133-1138.
35. Souza VA, Sumita LM, Freire W, Sato HK, Grandi JL, Pierrotti LC, Nascimento MC, Pannuti CS. 2004. Prevalence of antibodies to human herpesvirus-8 in populations with and without risk for infection in São Paulo State. Braz J Med Biol Res 37:123-127.
36. Spira TJ, Lam L, Dollard SC, Meng YX, Pau CP, Black JB, Burns D, Cooper B, Hamid M, Huong J, Kite-Powell K, Pellett PE. 2000. Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection. J Clin Microbiol 38:2174-2178.
37. Titanji K, De Milito A, Cagigi A, Thorstensson R, Grutzmeier S, Atlas A, Hejdeman B, Kroon FP, Lopalco L, Nilsson A, Chiodi F. 2006. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 108:1580-1587.
38. Zhu L, Wang R, Sweat A, Goldstein E, Horvat R, Chandran B. 1999. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65,1A, and K8.1B) replicative cycles and in immunofluorescence assays with KSHV-infected BCBL-1 cells. Virology 256:381-392.